177Lu-PSMA I&T_IRSTIRCCS
IRST185.09
Phase 2 small_molecule active
Quick answer
177Lu-PSMA I&T_IRSTIRCCS for Oligometastatic prostate carcinoma is a Phase 2 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Istituto Gentili S.r.l.
- Indication
- Oligometastatic prostate carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active